Pediatric Hematology and Oncology · 2007 · 15 citations · 15 references
MedicineOncologyPediatricsChemotherapyPediatric OncologyPediatric RadiologyLymphoma ImagingPediatric ChemotherapyPediatric LymphomasPediatric Oncology ImagingTherapy Response AssessmentAngiogenic BiomarkersHodgkin Lymphoma ImagingHodgkin Lymphoma TherapyPediatric Lymphoma ImagingPilot Study DesignPrognostic VariablesRestaging Of LymphomaTumor Growth Monitoring
This pilot study aimed at determining serum VEGF levels (S-VEGF) at diagnosis and at restaging in children with Hodgkin lymphoma, and investigating whether this parameter provides prognostic information for remission after 2 courses of chemotherapy. PET-CT fusion was performed to assess response to treatment. Changes in S-VEGF levels were found to correlate with response to treatment for most of the children. This provides a rationale for exploring clinical interest in S-VEGF measurements in a larger group of children with Hodgkin lymphoma, and using the test for clinical trials of anti-angiogenic therapies.
15
Petri Salvén, Arto Orpana, Lasse Teerenhovi et al. · Blood · 2000 · 225 citations
Medicine, Hematology, Oncology +10